StockNews.AI
KRMD
StockNews.AI
13 days

KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance

1. KRMD reported Q2 2025 net revenues of $10.2 million, up 21% year-over-year.

2m saved
Insight
Article

FAQ

Why Bullish?

The significant revenue growth indicates successful market penetration and operational efficiency, reminiscent of similar past performance boosts that positively influenced stock prices.

How important is it?

The revenue increase suggests positive business momentum, favorable for investor confidence and stock valuation.

Why Short Term?

Current financial results are likely to impact stock prices in the immediate quarters, based on historical trends where quarterly performance drives investor sentiment.

Related Companies

MEDPHSAFAXGN
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the second quarter ended June 30, 2025. Financial Highlights •   Second quarter 2025 net revenues of $10.2 million, a 21% increase over the prior year period       •   Core bus.

Related News